U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-QSB
QUARTERLY REPORT UNDER SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarter ended: Commission File Number:
September 30, 1996 33-90408-C
- -------------------------------- --------------------------------
PACE Health Management Systems, Inc.
(Exact name of small business issuer as specified in its charter)
Iowa 42-1297992
- ------------------------------- -------------------------------
(State or other jurisdiction of (IRS Employer Identification
incorporation or organization) Number)
1025 Ashworth Road
West Des Moines, IA 50265
-----------------------------------------------------------------
(Address and zip code of principal executive offices)
(515) 222-1717
-----------------------------------------------------------------
(Issuer's telephone number, including area code)
Check whether the issuer (1) filed all reports required to be filed by Section
13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12
months (or for such shorter period that the registrant was required to file such
reports), and (2) has been subject of the filing requirements for at least the
past 90 days. YES __x__ NO ____
State the number of shares outstanding of each of the issuer's classes of common
stock, as of the latest practicable date:
Number of Shares Outstanding
Class October 31, 1996
----- ----------------
Common Stock, no par 5,090,184
Transitional Small Business Disclosure Format (Check one): YES ___ NO __x__
PACE HEALTH MANAGEMENT SYSTEMS, INC.
PART I. FINANCIAL INFORMATION
Page
ITEM 1. FINANCIAL STATEMENTS ----
Condensed Balance Sheets.................................1
September 30, 1996 and December 31, 1995
Condensed Statements of Operations.......................2
Three Months and Nine Months Ended
September 30, 1996 and 1995
Condensed Statements of Cash Flows.......................3
Nine Months Ended September 30,
1996 and 1995
Notes to Condensed Financial Statements..................4
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR
PLAN OF OPERATION...........................................5
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS ..........................................9
ITEM 2. CHANGES IN SECURITIES.......................................9
ITEM 3. DEFAULTS UPON SENIOR SECURITIES.............................9
ITEM 4. SUBMISSION OF MATTERS TO A VOTE
OF SECURITY HOLDERS.........................................9
ITEM 5. OTHER INFORMATION..........................................10
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K...........................10
PART 1. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
<TABLE>
<CAPTION>
PACE HEALTH MANAGEMENT SYSTEMS, INC.
CONDENSED BALANCE SHEETS
- --------------------------------------------------------------------------------------
SEPT. 30, 1996 DEC. 31, 1995
-------------- -------------
ASSETS (UNAUDITED)
<S> <C> <C>
Current Assets:
Cash $ 2,557,477 $ 2,831,658
Accounts receivable, net 835,836 628,699
Inventories, primarily computer equipment 91,288 22,993
Prepaid expenses 51,498 37,056
------------ ------------
Total current assets 3,536,099 3,520,406
------------ ------------
Furniture and Equipment, at cost, net of
accumulated depreciation 517,534 378,879
------------ ------------
Computer Software Development Costs, net of
accumulated amortization:
Purchased 108,155 1,356,146
Internally developed 492,454 424,317
------------ ------------
600,609 1,780,463
------------ ------------
$ 4,654,242 $ 5,679,748
============ ============
LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities:
Current maturities of long-term obligations $ 15,458 $ 761,932
Accounts payable, customer deposits and
accrued expenses 965,262 463,914
------------ ------------
Total current liabilities 980,720 1,225,846
------------ ------------
Long-Term Obligations, less current maturities 36,248 47,663
------------ ------------
Shareholders' Equity:
Common stock 16,243,444 13,300,481
Additional paid-in capital 75,011 --
Accumulated deficit (12,681,181) (8,894,242)
------------ ------------
3,637,274 4,406,239
------------ ------------
$ 4,654,242 $ 5,679,748
============ ============
See Notes to Condensed Financial Statements.
</TABLE>
<TABLE>
<CAPTION>
PACE HEALTH MANAGEMENT SYSTEMS, INC.
CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)
- ----------------------------------------------------------------------------------------------------
THREE MONTHS ENDED NINE MONTHS ENDED
SEPTEMBER 30, SEPTEMBER 30,
--------------------------- ---------------------------
1996 1995 1996 1995
----------- ----------- ----------- -----------
<S> <C> <C> <C> <C>
Net revenues:
Systems revenues $ 424,281 $ 479,134 $ 1,854,127 $ 1,202,314
Customer support services 99,725 91,676 312,462 273,819
----------- ----------- ----------- -----------
524,006 570,810 2,166,589 1,476,133
----------- ----------- ----------- -----------
Costs and expenses:
Cost of systems revenues 314,669 192,918 598,275 384,739
Client services 257,338 267,330 626,818 621,105
Product development 565,085 231,531 1,312,977 560,644
Write-off of capitalized software 1,270,835 -- 1,270,835 --
Sales and marketing 274,835 233,416 890,615 602,939
General and administrative 378,053 333,607 1,302,573 824,611
----------- ----------- ----------- -----------
3,060,815 1,258,802 6,002,093 2,994,038
----------- ----------- ----------- -----------
Loss from operations (2,536,809) (687,992) (3,835,504) (1,517,905)
Other income, net 10,467 54,169 48,565 82,845
----------- ----------- ----------- -----------
Loss before income taxes (2,526,342) (633,823) (3,786,939) (1,435,060)
Provision for income taxes -- -- -- --
----------- ----------- ----------- -----------
Net loss $(2,526,342) $ (633,823) $(3,786,939) $(1,435,060)
=========== =========== =========== ===========
Loss per common
and common equivalent share $ (0.58) $ (0.15) $ (0.88) $ (0.52)
=========== =========== =========== ===========
Weighted average number of
common and common equivalent
shares outstanding 4,350,301 4,152,199 4,292,437 2,734,128
=========== =========== =========== ===========
See Notes to Condensed Financial Statements.
</TABLE>
<TABLE>
<CAPTION>
PACE HEALTH MANAGEMENT SYSTEMS, INC.
CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)
- -----------------------------------------------------------------------------------------
NINE MONTHS ENDED
SEPTEMBER 30,
---------------------------
CASH FLOWS FROM OPERATING ACTIVITIES 1996 1995
----------- -----------
<S> <C> <C>
Net Loss $(3,786,939) $(1,435,060)
Adjustments to reconcile net loss to net cash (used in)
operating activities:
Depreciation 150,287 71,204
Amortization 192,579 154,290
Write-off of capitalized software 1,270,835 --
Compensation expense recognized upon
grant of stock option 75,011 --
Change in assets and liabilities:
(Increase) in accounts receivable (207,137) (491,143)
(Increase) in other current assets (82,737) (63,979)
Increase (decrease) in other current liabilities 501,348 (81,651)
----------- -----------
Net cash (used in) operating activities (1,886,753) (1,846,339)
----------- -----------
CASH FLOWS FROM INVESTING ACTIVITIES
Capitalized computer software development costs (283,560) (133,700)
Purchase of furniture and equipment (288,942) (283,524)
----------- -----------
Net cash (used in) investing activities (572,502) (417,224)
----------- -----------
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from notes payable 450,000 500,000
Proceeds from sale of preferred stock -- 38,433
Proceeds from sale of common stock 2,942,963 5,500,722
Proceeds from stock subscriptions receivable -- 881,285
Payments on notes payable and long term obligations (1,207,889) (1,254,645)
----------- -----------
Net cash provided by financing activities 2,185,074 5,665,795
----------- -----------
Net increase (decrease) in cash (274,181) 3,402,232
CASH
Beginning 2,831,658 112,203
----------- -----------
Ending $ 2,557,477 $ 3,514,435
=========== ===========
SUPPLEMENTAL DISCLOSURES OF CASH
FLOWS INFORMATION
Cash payments for interest $ 3,620 $ 21,847
SUPPLEMENTAL SCHEDULE OF NONCASH
INVESTING AND FINANCING ACTIVITIES
Issuance of Series H preferred stock for release
of note payable to shareholder $ -- $ 109,650
Accrued interest converted to long-term obligation -- 13,886
Repayment of notes payable with proceeds assigned
as collateral -- 500,000
See Notes to Condensed Financial Statements
</TABLE>
PACE HEALTH MANAGEMENT SYSTEMS, INC.
NOTES TO CONDENSED FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
NOTE 1. BASIS OF PRESENTATION
The accompanying financial information should be read in conjunction with the
annual financial statements and notes thereto for the year ended December 31,
1995. The financial information included herein is unaudited; such information
reflects all adjustments which, in the opinion of management, are necessary in
order to make the financial statements not misleading.
The results of operations for the nine months are not necessarily indicative of
the results to be expected for the entire fiscal year.
NOTE 2. LOSS PER COMMON SHARE AND COMMON EQUIVALENT SHARE
Loss per common and common equivalent share is based on the weighted average
number of common and common equivalent shares outstanding during the period.
Common equivalent shares consist of stock options and warrants (using the
treasury stock method). Common equivalent shares are excluded from the
computation if their effect is anti-dilutive, except that, pursuant to
Securities and Exchange Commission Staff Accounting Bulletin No. 83, stock
options and warrants granted with exercise prices below the initial public
offering price during the twelve month period preceding the date of the initial
filing of the Registration Statement have been included in the computation as if
they were outstanding for all years presented.
NOTE 3. RECLASSIFICATION
Certain costs and expenses on the Statements of Operations for the three and
nine month periods ended September 30, 1995 have been reclassified with no
effect on income.
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION
GENERAL. PACE Health Management Systems, Inc. ("PACE" or the "Company") was
organized in 1987 as a computer systems consulting firm. In 1989, the Company
began to develop and market a nursing station care plan management system built
around a knowledge base or "Clinical Library" developed over a period of 20
years at Carnegie-Mellon and Creighton Universities. In late 1992, the Company
recognized what it believed to be a significant opportunity for software
applications integrated with the Clinical Library to address the point-of-care
clinical information systems market and began to develop the PACE Clinical
Information System ("PACE/CIS"). In early 1993, the Company discontinued
marketing the nursing station care plan management system as a stand-alone
product and focused on development of PACE/CIS. In 1995, the Company introduced
PACE CMS, a comprehensive care management system which includes order management
and results reporting, clinical pathway management and clinical repository
modules, in addition to the Clinical Library database and point-of-care
applications. In the third quarter of 1996, the Company introduced a
state-of-the-art three-tier graphical version of PACE CMS.
Prior to April 1995, the Company financed operations with capital contributed by
private investors. In April 1995, the Company completed its initial public
offering, selling 1,300,000 shares of Common Stock at $5.00 per share for net
proceeds to the Company of $5,500,722. Effective as of the closing of the
initial public offering, all outstanding shares of the Company's preferred stock
(the "Preferred Stock") issued during previous rounds of private financing were
converted to Common Stock on a one-to-one basis. In September, 1996, the Company
sold 900,000 shares of common stock at $3.25 per share for net proceeds to the
Company of $2,802,845.
The Company derives substantially all of its revenues from the sale of PACE
systems including: (a) software license fees, (b) implementation fees and (c)
hardware sales. Following implementation of the software, the Company also
generally receives monthly revenues for customer support services. Customer
support services include revenue from maintenance and support services,
miscellaneous customization following implementation, and consulting services.
The Company recognizes revenues in accordance with Statement of Position 91-1,
"Software Revenue Recognition," which requires that systems be delivered,
collectibility be probable and there be no significant uncertainty about
acceptance. The Company generally records software license fees and
implementation fees over the period of implementation. Revenues from hardware
sales are generally recorded at the time of delivery and customer support
services revenue is recorded monthly.
The Company capitalizes software development costs that relate primarily to
either the development of new software or significant enhancements to existing
software. Software costs are capitalized in accordance with Statement of
Financial Accounting Standards No. 86, "Accounting for the Costs of Computer
Software to be Sold, Leased, or Otherwise Marketed," which requires
capitalization of expenses following determination of technical feasibility and
until the software is ready for general release. The capitalized costs are
amortized by the greater of (a) the ratio that current gross revenues for
software sales bear to the total of current and anticipated future gross
revenues for such software sales, or (b) the straight-line method over the
estimated economic life of the software, usually three to seven years. At each
balance sheet date, the unamortized capitalized costs of a computer software
product are compared to the net realizable value of the product and the amount
by which the unamortized capitalized costs exceed the net realizable value is
written off. The net realizable value is the estimated future gross revenues
from a product, reduced by the estimated future costs of completing and
disposing of that product.
RESULTS OF OPERATIONS
NET REVENUES: Net revenues include systems revenue and customer support
services. Net revenues were $570,810 and $524,006 for the three months ended
September 30, 1995 and 1996, respectively, representing a decrease of 8.2%.
Systems revenue comprised 83.9% and 80.9% of total net revenues for the three
months ended September 30, 1995 and 1996, respectively. Net revenues were
$1,476,133 and $2,166,589 for the nine months ended September 30, 1995 and 1996,
respectively, representing an increase of 46.8%. Systems revenue comprised 81.5%
and 85.6% of total net revenues for the nine months ended September 30, 1995 and
1996, respectively. The increase in net revenues for the nine month period was
primarily due to recognition of systems revenue on a 20-site license agreement,
following acceptance of a pilot project from a healthcare provider with a
nationwide network of 37 rehabilitation hospitals.
Systems revenue from this healthcare provider accounted for $255,920 or 60.3% of
systems revenue for the three month period ended September 30, 1996 of which
93.6% was attributable to hardware sales on follow on orders for equipment
delivered to additional sites. Systems revenue from this healthcare provider
accounted for $1,261,047 or 68.0% of the systems revenue for the nine month
period ended September 30, 1996, of which 27.3% was attributable to hardware
sales. While the Company anticipates future hardware sales to this healthcare
provider to be a large part of systems revenue, the percentage of hardware sales
to total systems revenue may fluctuate depending on the mix of software license
fees, implementation fees, and hardware sales to new customers. Further, future
revenues may be subject to quarterly fluctuations due to various factors,
including long sales cycles, timing of orders or contracts, and the duration of
implementation.
COST OF SYSTEMS REVENUES: Cost of systems revenues includes hardware purchases,
commissions and royalties payable to third parties. Cost of systems revenues was
$192,918 and $314,669 in the three months ended September 30, 1995 and 1996,
respectively, representing an increase of 63.1%. Cost of systems revenues was
$384,739 and $598,275 in the nine months ended September 30, 1995 and 1996
respectively, representing an increase of 55.5%. Costs of systems revenues
totaled 33.8% and 60.0%, respectively, of total net revenues for the three
months ended September 30, 1995 and 1996 and cost of systems revenues totaled
26.0% and 27.6%, respectively, of total net revenues for the nine months ended
September 30, 1995 and 1996. The increase for both the three month and nine
month period was primarily as a result of costs associated with increased
hardware sales. While the nine month figures are probably more indicative of the
expected cost of systems revenues as a percentage of net revenues, this figure
will continue to fluctuate in the future, depending on the relative mix of
hardware and software.
CLIENT SERVICES: Client services expenses include salaries and expenses related
to implementation, installation and support. Client services expenses were
$267,330 and $257,338 for the three months ended September 30, 1995 and 1996,
respectively, representing a decrease of 3.7%. Client services expenses were
$621,105 and $626,818 for the nine months ended September 30, 1995 and 1996,
respectively, representing an increase of 0.9%. While Client services expenses
have remained relatively constant from 1995 to 1996, the Company expects these
expenses will increase in the future, although client services expenses as a
percentage of net revenues may fluctuate from period to period.
PRODUCT DEVELOPMENT: Product development expenses include salaries and expenses
related to development and documentation of software systems, net of capitalized
software development costs. Product development expenses were $231,531 and
$565,085 for the three months ended September 30, 1995 and 1996, respectively,
representing an increase of 144.1%. Product development expenses were $560,644
and $1,312,977 for the nine months ended September 30, 1995 and 1996,
respectively, representing an increase of 134.2%. These increases were primarily
due to increases in personnel and payroll related expenses as the Company
accelerated work on its Graphical User Interface (GUI) project and expanded
staffing on its Critical Pathway Analyzer (CPA) project. The Company capitalized
$4,508 and $79,461 of product development costs and amortized $70,365 and
$72,289 in the three months ended September 30, 1995 and 1996, respectively. The
Company capitalized $133,700 and $283,560 of product development costs and
amortized $154,290 and $192,579 in the nine months ended September 30, 1995 and
1996, respectively. The increased efforts associated with the GUI and CPA
projects accounted for the increases in capitalized expenses in the periods
presented. The Company expects that product development expenses will increase
in the future, although product development expenses as a percentage of revenues
may fluctuate from period to period.
WRITE-OFF OF CAPITALIZED SOFTWARE: Write-off of capitalized software reflects a
one-time adjustment of $1,270,835 during the three months ended September 30,
1996. This write-off reflects the unamortized costs of developing the Company's
original text-based version of CMS. This version of the product will no longer
be offered for sale and, as a result, any net realizable value to the Company
for that product is minimal. This adjustment was made following the Company's
delivery and implementation of its new three-tier Graphical User Interface
Solution (GUI) during the third quarter of 1996.
SALES AND MARKETING: Sales and marketing expenses include salaries, advertising,
trade show costs and travel expenses related to the sale and marketing of the
Company's systems. Sales and marketing expenses were $233,416 and $274,835 for
the three months ended September 30, 1995 and 1996, respectively, representing
an increase of 17.7%. Sales and marketing expenses were $602,939 and $890,615
for the nine months ended September 30, 1995 and 1996, respectively,
representing an increase of 47.7%. The increases in the three and nine month
periods were primarily due to increases in personnel and payroll related
expenses as the Company expanded its sales department. The Company expects the
level of sales and marketing expenses will increase in the future, although
sales and marketing expenses as a percentage of net revenues may fluctuate from
period to period.
GENERAL AND ADMINISTRATIVE: General and administrative expenses include salaries
and expenses for the corporate administration and finance, legal, insurance,
rent and depreciation expenses. General and administrative expenses were
$333,607 and $378,053 for the three months ended September 30, 1995 and 1996,
respectively, representing an increase of 13.3%. General and administrative
expenses were $824,611 and 1,302,573 for the nine months ended September 30,
1995 and 1996, respectively, representing an increase of 58%. This increase was
primarily due to an increase in professional services, an increase in rent
expense following the Company's expansion of office space in West Des Moines,
Iowa, and an increase in insurance expense related to the Company's director's
and officer's liability coverage. In addition, the Company incurred one-time
costs of approximately $300,000 associated with the recruiting and hiring of the
Company's new Chief Executive Officer in March 1996.
OTHER INCOME, NET: Other income, net is comprised of interest income and
expenses. Other income, net was $54,169 and $10,467 for the three months ended
September 30, 1995 and 1996, respectively, representing a decrease of 80.7%.
Other income, net was $82,845 and $48,565 for the nine months ended September
30, 1995 and 1996, respectively, representing a decrease of 41.4%. Following
completion of the initial public offering in April 1995, cash balances and
investments increased substantially, resulting in increased interest income
beginning in the second quarter of 1995. In addition, interest expense was
reduced following the repayment of $500,000 in bridge notes in April 1995 with
proceeds from the initial public offering.
PROVISION FOR INCOME TAXES: No provision for income tax benefit has been
recorded due to the Company recording a valuation allowance on the deferred tax
assets.
LIQUIDITY AND CAPITAL RESOURCES
Since its inception, the Company has experienced annual operating losses and
negative cash flows from operations. The Company's primary source of cash and
working capital has been from investor funds. Cash used in operating activities
was $1,846,339 and $1,886,753 for the nine month periods ended September 30,
1995 and 1996, respectively. In 1995, cash provided by financing activities was
$5,665,795 which included net proceeds from the initial public offering in the
amount of $ 5,500,722, proceeds from the collections of stock subscriptions
receivable in the amount of $881,285, and repayment of long term obligations in
the amount of $754,645. In 1996, cash provided by financing activities was
$2,185,074 which included net proceeds from the sale of 900,000 shares of common
stock in the amount of $2,802,845 and repayment of long term obligations in the
amount of $757,889. In 1996, the Company also funded its operations in part
through periodic borrowings under its unsecured line of credit.
Accounts receivable of $628,699 as of December 31, 1995 increased $207,137 to
$835,836 as of September 30, 1996 as revenues continued to increase. The Company
has established an allowance for doubtful accounts which management believes is
adequate. Included in accounts receivable are unbilled accounts receivable of
$520,150 that were recognized in revenue prior to when payments were due to the
Company under the terms of the customer contracts.
Other current liabilities of $463,914 as of December 31, 1995 increased $501,348
to $965,262 as of September 30, 1996. This increase was primarily due to an
increase in customer deposits of $194,067 received by the Company in advance of
revenue recognition and an increase in accounts payable of $243,622 resulting
from an increase in hardware purchased for resale. For the nine months ended
September 30, 1995 and 1996, the Company incurred $133,700 and $283,560,
respectively, in capital expenditures which consisted of computer equipment
utilized primarily in research and development, and sales demonstration
equipment.
The Company occupies approximately 11,500 square feet of office space at its
headquarters in West Des Moines, Iowa, under a lease expiring in May 1997. In
addition, the Company occupies approximately 1,200 square feet in Charlotte,
North Carolina under a lease expiring in May 1998. The Company believes its
facilities are adequate to satisfy its currently anticipated business
requirements through May 1997.
As of September 30, 1996, the Company had working capital of $2,555,379,
including a cash balance of $2,557,477. At that date, the Company did not have
material long-term obligations or commitments for capital expenditures. As of
May 31, 1996, the Company entered into a $1.0 million unsecured line of credit
at a variable interest rate (8.25% as of September 30, 1996) under which no
amount was outstanding as of September 30, 1996. The line of credit expires on
April 30, 1997. The Company anticipates it will be required to raise additional
funds during 1997 and is currently evaluating alternatives.
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS.
N/A
ITEM 2. CHANGES IN SECURITIES.
N/A
ITEM 3. DEFAULTS UPON SENIOR SECURITIES.
N/A
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.
The annual meeting of shareholders of PACE Health Management Systems, Inc. was
held at the office of the Company, 1025 Ashworth Road, City of West Des Moines,
on May 3, 1996. The following matters were voted upon:
1. Proposal to restate the Articles of Incorporation:
For: 3,510,569 Against: 73,375 Abstentions: 2,470
--------- ------ -----
2. Election of Directors:
Name Votes Received Term
---- -------------- ----
Bill Childs 3,564,958 1 year
David Spreng 3,564,958 1 year
John Pappajohn 3,564,958 2 years
Gordon Derzon 3,564,958 2 years
Mark Emkjer 3,564,958 3 years
Carl Witonsky 3,564,958 3 years
3. Proposal to ratify the appointment of McGladrey & Pullen, LLP, as
independent auditors:
For: 3,583,489 Against: 1,500 Abstentions: 1,425
--------- ----- -----
ITEM 5. OTHER INFORMATION.
N/A
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
(a) Exhibits
Exhibit 27 - Financial Data Schedule
(b) Reports on Form 8-K
No reports on Form 8-K were filed during the quarter
for which this report is filed.
SIGNATURES
In accordance with requirements of the Exchange Act, the registrant caused
this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
PACE HEALTH MANAGEMENT SYSTEMS, INC.
- ------------------------------------
(Registrant)
November 8, 1996 /s/ ROGER D. HUSEMAN
- ---------------- ------------------------------------
Dated Roger D. Huseman, Vice President and
Chief Financial Officer
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-1996
<PERIOD-START> JAN-01-1996
<PERIOD-END> SEP-30-1996
<CASH> 2,557,477
<SECURITIES> 0
<RECEIVABLES> 884,029
<ALLOWANCES> 48,193
<INVENTORY> 91,288
<CURRENT-ASSETS> 3,536,099
<PP&E> 950,760
<DEPRECIATION> 433,226
<TOTAL-ASSETS> 4,654,242
<CURRENT-LIABILITIES> 980,720
<BONDS> 0
0
0
<COMMON> 16,243,444
<OTHER-SE> (12,606,170)
<TOTAL-LIABILITY-AND-EQUITY> 4,654,242
<SALES> 2,166,589
<TOTAL-REVENUES> 2,166,589
<CGS> 1,225,093
<TOTAL-COSTS> 6,002,093
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 4,374
<INCOME-PRETAX> (3,786,939)
<INCOME-TAX> 0
<INCOME-CONTINUING> (3,786,939)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (3,786,939)
<EPS-PRIMARY> (.88)
<EPS-DILUTED> (.88)
</TABLE>
